2017
DOI: 10.1017/s0954422416000263
|View full text |Cite
|
Sign up to set email alerts
|

Improving selection of markers in nutrition research: evaluation of the criteria proposed by the ILSI Europe Marker Validation Initiative

Abstract: The conduct of high-quality nutrition research requires the selection of appropriate markers as outcomes, for example as indicators of food or nutrient intake, nutritional status, health status or disease risk. Such selection requires detailed knowledge of the markers, and consideration of the factors that may influence their measurement, other than the effects of nutritional change. A framework to guide selection of markers within nutrition research studies would be a valuable tool for researchers. A multidis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 23 publications
0
4
0
Order By: Relevance
“…It is becoming more pertinent that the conduct of nutrition research requires meaningful composite biomarkers, which may provide a more effective means for monitoring disease progression and response to intervention than the individual biomarkers [11]. These biomarkers may include dietary exposure, nutritional status, or physiological function, which, in turn, influence health and disease risk [12]. A state of oxidative stress can be measured through increased production of prooxidant compounds and depletion of antioxidants [13].…”
Section: Introductionmentioning
confidence: 99%
“…It is becoming more pertinent that the conduct of nutrition research requires meaningful composite biomarkers, which may provide a more effective means for monitoring disease progression and response to intervention than the individual biomarkers [11]. These biomarkers may include dietary exposure, nutritional status, or physiological function, which, in turn, influence health and disease risk [12]. A state of oxidative stress can be measured through increased production of prooxidant compounds and depletion of antioxidants [13].…”
Section: Introductionmentioning
confidence: 99%
“…Generally, we defined consistently associated risk factors as those for which more than 50% of studies report an association in the same direction, in at least two studies of moderate or high quality. Based on the International Life Sciences Institute (ILSI) Europe Marker Validation Initiative, we developed and piloted a criteria template for quality assessment of risk factors 21 ( Table S1 ). Based on methodological aspects, the study objective, modifiability, predictiveness, and early-life risk factors were evaluated.…”
Section: Methodsmentioning
confidence: 99%
“…In addition, although biomarkers of intake, which are more objectively quantifiable, can replace self-report for some purposes, only a few nutrients have validated biomarkers. Lastly, no one single approach accurately measures dietary intake in a comprehensive manner for all nutrients, thus each study methodology must be assessed based on its own merits (40).…”
Section: Challenges For Future Dris With Chronic Disease Endpointsmentioning
confidence: 99%
“…However, outcome measures may be flawed, and sufficient data on associations between nutrient exposure and expected outcome do not always exist. The criteria for a qualified surrogate marker are 1) that analytical validation exists; 2) the surrogate marker is on the causal pathway in disease pathogenesis; 3) the surrogate marker is significantly associated with the disease in a target population; 4) the surrogate marker consistently changes with the health outcome in response to a nutritional intervention; 5) a change in the surrogate marker supports a substantial change in the disease response to exposure to the nutrient or food substance; and 6) the context of the surrogate's use is defined (40,41). The committee supported the option that studies that measure qualified surrogate markers should be considered when evaluating evidence for a causal relation; however, it did not support using nonqualified intermediate markers, because they could lead to serious misinterpretation of DRIs by users (34).…”
Section: Challenges For Future Dris With Chronic Disease Endpointsmentioning
confidence: 99%